Upcoming Programs
|
Hybrid CME Opportunity Advances and Innovations in Endoscopic Oncology and Multidisciplinary Gastrointestinal Cancer Care Saturday, April 15, 2023 In-person event: Omni Resort and Spa at Montelucia, Scottsdale, AZ Virtual livestream: Zoom Click Here for More Information |
This program is designed to improve the knowledge base of the oncology multidisciplinary team, including gastroenterologists, about the expanding role and procedures of interventional endoscopy in cancer care with focus on gastrointestinal malignancies. A panel of expert speakers will provide updates on guidelines in GI cancer screening, diagnosis, staging and palliation with special emphasis on the cancer population.
LEARNING OBJECTIVES:
Upon completion of this program, participants will be able to:
• Recognize the expanding role of the interventional gastroenterologist in the care of gastrointestinal malignancies
• Review updates on the recently introduced technology and procedures in interventional gastroenterology relevant to cancer
care
• Identify the indications and expected outcomes of commonly performed therapeutic endoscopic procedures in cancer patients
• Review the National Comprehensive Cancer Network guidelines relevant to the practice of gastroenterology.
WHO SHOULD ATTEND:
• Medical Oncologists • Surgical Oncologists • Gastroenterologists • Advanced Practice Providers
• Palliative Care Providers • Interventional Oncologists • GI Fellows
To register, or for more information, scan the QR code or visit:
www.cancercenter.com/physicians/continuing-medicaleducation#gi-advances-2023
LEARNING OBJECTIVES:
Upon completion of this program, participants will be able to:
• Recognize the expanding role of the interventional gastroenterologist in the care of gastrointestinal malignancies
• Review updates on the recently introduced technology and procedures in interventional gastroenterology relevant to cancer
care
• Identify the indications and expected outcomes of commonly performed therapeutic endoscopic procedures in cancer patients
• Review the National Comprehensive Cancer Network guidelines relevant to the practice of gastroenterology.
WHO SHOULD ATTEND:
• Medical Oncologists • Surgical Oncologists • Gastroenterologists • Advanced Practice Providers
• Palliative Care Providers • Interventional Oncologists • GI Fellows
To register, or for more information, scan the QR code or visit:
www.cancercenter.com/physicians/continuing-medicaleducation#gi-advances-2023
|
Local/Regional Live and Virtual Meeting Series
Phoenix Society of Gastroenterology Date: Wednesday, April 19, 2023 Time: 6:00 pm – 7:00 pm MT For full accreditation information and to register, visit: www.clinicaloptions.com/NASH2023 Suggested Browsers: Apple Safari, Google Chrome, or Mozilla Firefox |
PROGRAM OVERVIEW
The Phoenix Society of Gastroenterology cordially invites you to attend an CME/ABIM MOC‒certified presentation titled, “A Metabolic Approach to NASH Management.” This activity will provide gastroenterologists and hepatologists who treat and manage patients with nonalcoholic steatohepatitis (NASH) with the latest information on how to develop personalized multidisciplinary treatment plans to optimize the care of patients with NASH, as well as a discussion of emerging metabolic therapies for NASH treatment. The program will be presented for free, at no cost to the institution or the learners.
LEARNING OBJECTIVES
• Describe the metabolic nature of NASH pathophysiology
• Explain the relationship between NASH, obesity, and diabetes
• Determine appropriate strategies for early intervention and treatment in patients with NASH
• Evaluate emerging metabolic therapies for the management of patients with NASH
ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION STATEMENT: The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC RECOGNITION STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
FEE AND RECEIVING CME CREDIT/MOC POINTS: There is no fee for this activity. To receive credit, participants must register, view the live CME/MOC activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the posttest multiple times. Disclosures will be made known to participants before the activity. Jointly provided by the Potomac Center for Medical Education and Rockpointe, and supported by an educational grant from Novo Nordisk.
The Phoenix Society of Gastroenterology cordially invites you to attend an CME/ABIM MOC‒certified presentation titled, “A Metabolic Approach to NASH Management.” This activity will provide gastroenterologists and hepatologists who treat and manage patients with nonalcoholic steatohepatitis (NASH) with the latest information on how to develop personalized multidisciplinary treatment plans to optimize the care of patients with NASH, as well as a discussion of emerging metabolic therapies for NASH treatment. The program will be presented for free, at no cost to the institution or the learners.
LEARNING OBJECTIVES
• Describe the metabolic nature of NASH pathophysiology
• Explain the relationship between NASH, obesity, and diabetes
• Determine appropriate strategies for early intervention and treatment in patients with NASH
• Evaluate emerging metabolic therapies for the management of patients with NASH
ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION STATEMENT: The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC RECOGNITION STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
FEE AND RECEIVING CME CREDIT/MOC POINTS: There is no fee for this activity. To receive credit, participants must register, view the live CME/MOC activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the posttest multiple times. Disclosures will be made known to participants before the activity. Jointly provided by the Potomac Center for Medical Education and Rockpointe, and supported by an educational grant from Novo Nordisk.